MetaVia Inc. (MTVA)
D
Pipeline Grade
Financial Position (from SEC Filings)
$13.7M
Cash & Equivalents
$4.3M
Quarterly Burn Rate
10 mo
Est. Cash Runway
$9M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-11-09 | Phase1 Readout | — |
Active Clinical Trials (1)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06252220 | First in Human Study in Subjects With Obesity, But Otherwise Healthy | PHASE1 | Recruiting | 139 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.